| [1] |
Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage Ⅱ or Ⅲ colon cancer in the MOSAIC trial[J]. J Clin Oncol, 2009, 27(19):3109-3116.
|
| [2] |
Haller DG, Tabernero J, Maroun J, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage Ⅲ colon cancer[J]. J Clin Oncol, 2011, 29(11):1465-1471.
|
| [3] |
Yothers G, O′Connell MJ, Allegra CJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses[J]. J Clin Oncol, 2011, 29(28):3768-3774.
|
| [4] |
Breugom AJ, Swets M, Bosset JF, et al. Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data[J]. Lancet Oncol, 2015, 16(2):200-207.
|
| [5] |
Borowski DW, Bradburn DM, Mills SJ, et al. Northern Region Colorectal Cancer Audit G: Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg, 2010, 97(9):1416-1430.
|
| [6] |
Paun BC, Cassie S, MacLean AR, et al. Postoperative complications following surgery for rectal cancer[J]. Ann Surg, 2010, 251(5):807-818.
|
| [7] |
Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase Ⅱ randomized trialdagger[J]. Ann Oncol, 2015, 26(8):1722-1728.
|
| [8] |
Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase Ⅱ, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study[J]. J Clin Oncol, 2010, 28(5):859-865.
|
| [9] |
Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial[J]. J Clin Oncol, 1999, 17(8):2396.
|
| [10] |
Glehen O, Chapet O, Adham M, et al. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer[J]. Br J Surg, 2003, 90(8):996-998.
|
| [11] |
Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer[J]. Br J Surg, 2013, 100(7):933-939.
|
| [12] |
Garcia-Aguilar J, Chow OS, Smith DD, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial[J]. Lancet Oncol, 2015, 16(8):957-966.
|
| [13] |
Nilsson PJ, van Etten B, Hospers GA, et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial[J]. BMC Cancer, 2013, 13:279.
|